PRR24 inhibitors refer to a class of chemical compounds designed to target and inhibit the activity of the PRR24 protein or gene product. PRR24 is part of the proline-rich family of proteins, which typically play roles in signaling pathways, protein-protein interactions, and cellular communication. These inhibitors work by selectively binding to the PRR24 protein, blocking its normal function and interaction with other cellular components. By modulating the activity of PRR24, these inhibitors can affect various biochemical processes within cells, depending on the context in which the protein operates. Since proteins like PRR24 are often involved in the regulation of gene expression, signal transduction, and structural organization within cells, the inhibition of PRR24 may lead to changes in cell behavior, including alterations in cell proliferation, differentiation, or migration.
The development of PRR24 inhibitors relies on the deep understanding of the protein's structure, its binding sites, and the pathways it influences. Computational modeling, crystallography, and other structural biology tools are frequently employed to map the interaction sites and design molecules that can efficiently block PRR24 activity. Additionally, studies on the specificity of PRR24 inhibitors ensure that these compounds have minimal off-target effects, avoiding unintended interactions with other proteins in the cell. Biochemical assays are often used to monitor the efficacy of these inhibitors in different cellular systems, shedding light on the mechanistic roles that PRR24 plays in a variety of biological contexts. This type of inhibitor provides a powerful tool for researchers aiming to dissect the molecular functions of PRR24 in basic cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Cholesterol-lowering drug inhibiting HMG-CoA reductase. Impacts membrane integrity, altering INAFM1 localization and function as a membrane integral component. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor suppressing phosphoinositide 3-kinase activity. Indirectly influences INAFM1, disrupting its membrane integration and predicted integral role. | ||||||
Amphotericin B | 1397-89-3 | sc-202462 sc-202462A sc-202462B | 100 mg 500 mg 1 g | $70.00 $142.00 $223.00 | 10 | |
Antifungal agent disrupting membrane integrity. Affects INAFM1 localization, influencing its function as an integral component of the membrane. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress by inhibiting SERCA pump. Alters INAFM1 function as a membrane integral component due to ER stress-induced changes. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK pathway influencing membrane dynamics. Indirectly modulates INAFM1, impacting its role as an integral component of the membrane. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Sphingolipid synthesis inhibitor affecting membrane composition. Alters INAFM1 membrane localization, influencing its function as a predicted integral component. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits autophagy by blocking vacuolar H+-ATPase. Indirectly influences INAFM1, impacting its presence in the membrane as an integral component. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor suppressing mammalian target of rapamycin. Indirectly affects INAFM1, disrupting its role as an integral component of the membrane. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, impacting endocytosis and membrane dynamics. Alters INAFM1 membrane integration, influencing its function as an integral component. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpain inhibitor suppressing calpain activity. Indirectly modulates INAFM1, disrupting its role as a predicted integral component of the membrane. | ||||||